BCL2L12 and central nervous system cancer: To neutralize Bcl2L12 expression in an established glioma, Jensen et al. [14] and Kouri et al. [18] comprehensively characterized SNAs with gold nanoparticle templates that carry Bcl2L12-targeting siRNA or miR-182 oligonucleotides, respectively (Figure 2).